{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T22:12:07Z","timestamp":1774044727228,"version":"3.50.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CGT"],"published-print":{"date-parts":[[2026,3,16]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract::<\/jats:title>\n                    <jats:p>Haemophilia, a genetic bleeding disorder predominantly affecting males, arises from deficiencies\nor dysfunctions in clotting factors VIII or IX. Conventional treatments, such as frequent\nintravenous infusions of clotting factor concentrates, pose challenges in terms of cost, accessibility,\nand patient adherence. Gene therapy offers a transformative solution by correcting genetic mutations,\nenabling the body to produce clotting factors endogenously. Indian scientists have recently\npioneered advances in this field, employing adeno-associated viral vectors for efficient and safe\ngene delivery. This approach addresses limitations of traditional therapies, including the development\nof inhibitors and the need for repetitive infusions. With the integration of cutting-edge genome\nediting technologies, such as CRISPR\/Cas9, hemophilia treatment is poised for long-term efficacy\nand improved quality of life. Despite these promising developments, challenges remain, including\naffordability, ethical considerations, and equitable access. This paper highlights the latest breakthroughs,\nclinical advancements, and future directions in gene therapy for hemophilia, emphasizing\nIndia\u2019s significant contributions to global research. The findings underscore the potential of gene\ntherapy to shift hemophilia management from routine care to curative strategies, redefining therapeutic\npossibilities for this chronic condition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115665232391816251126073522","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:28:02Z","timestamp":1774038482000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gene Therapy for Hemophilia: Innovations, Milestones, and Future Prospects"],"prefix":"10.2174","volume":"26","author":[{"given":"Dinesh","family":"Kumar","sequence":"first","affiliation":[{"name":"School of Pharmacy, Desh Bhagat University, Mandi Gobindgarh, Punjab, Fatehgarh Sahib, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vrinda","family":"Gupta","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Desh Bhagat University, Mandi Gobindgarh, Punjab, Fatehgarh Sahib, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajni","family":"Tanwar","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Desh Bhagat University, Mandi Gobindgarh, Punjab, Fatehgarh Sahib, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicky Kumar","family":"Jaiswal","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Desh Bhagat University, Mandi Gobindgarh, Punjab, Fatehgarh Sahib, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Gupta","sequence":"additional","affiliation":[{"name":"Swami Devi Dyal Group of Professional Institute, Panchkula, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115665232391816251126073522","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/250968\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115665232391816251126073522","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:28:40Z","timestamp":1774038520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/250968\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115665232391816251126073522","relation":{},"ISSN":["1566-5232"],"issn-type":[{"value":"1566-5232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-03-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}